LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10115-1 | LDN-193189 | DM 3189 | LSM-1115 | 25195294 | |
10116-1 | PF431396 | LSM-1116 | 11598628 | ||
10117-1 | Celastrol | LSM-1117 | 5315765 | ||
10120-1 | Canertinib | CI-1033; PD-183805 | LSM-1120 | 156414 | |
10126-1 | PI103 | LSM-1126 | 9884685 | ||
10127-1 | Dovitinib | TKI_258; TKI258 | LSM-1127 | 49830557 | |
10128-1 | GSK 690693 | LSM-1128 | 16048642 | ||
10132-1 | SNS-032 | BMS-387032 | LSM-1132 | 3025986 | |
10134-1 | GSK1904529A | LSM-1134 | 25124816 | ||
10135-1 | Linsitinib | OSI 906 | LSM-1135 | 11640390 | |
10138-1 | Ruxolitinib | LSM-1139 | 25126798 | ||
10140-1 | Momelotinib | CYT387 | LSM-1141 | 25062766 | |
10141-1 | Fedratinib | SAR 302503; SAR-302503; SAR302503; TG 101348; Tg-101348; TG101348 | LSM-1142 | 16722836 | |
10142-1 | Trametinib | GSK-1120212; GSK1120212; GSK1120212B; JTP-74057 | LSM-1143 | 11707110 | |
10146-1 | Omipalisib | GSK2126458; GSK2126458A | LSM-1147 | 25167777 | |
10147-1 | Buparlisib | BKM120; NVP-BKM120 | LSM-1148 | 16654980 | |
10148-1 | XL147 | SAR245408 | LSM-1149 | 52914932 | |
10149-1 | Y39983 | LSM-1150 | 9810884 | ||
10151-1 | Nintedanib | BIBF-1120; Vargatef | LSM-1152 | 56965894 | |
10157-1 | Foretinib | XL880; GSK1363089 | LSM-1158 | 42642645 | |
10158-1 | AZD 5438 | KIN001-239 | LSM-1159 | 16747683 | |
10159-1 | Pelitinib | EKB-569 | LSM-1160 | 216467 | |
10161-1 | Luminespib | NVP-AUY922 | LSM-1162 | 53401173 | |
10164-1 | AZD8330 | ARRY-424704; ARRY-704 | LSM-1165 | 16666708 | |
10171-1 | TGX221 | LSM-1172 | 9907093 |